gsk, page-14

hi surges , "Now we are still in ex-vivo studies and possibly move into in-vivo studies in the coming year in the slowest of all sectors our technologies might applied to, the pharmaceutical sector."


I believe that this ids different as its GSK US paharma , this is different to the other studies conducted with the tooth-care side of GSK .if I am correct then it will take a while and will depend on whether its OTC or prescription .

Either way Surges , I am happy to wait as I think that we will have other deals coming up soon enough on different fronts . We have waited this long , whats another 6-12 months ?